New Trustee joins the Board of Our Future Health
Role of the Board of Trustees
Our Future Health is governed by a Board of Trustees, which is responsible for the policies, activities and assets of Our Future Health and provides strategic leadership. Trustees serve on the Board in a voluntary capacity and do not receive remuneration.
By expanding our Board of Trustees, we’re bringing in additional skills, new ideas and diverse, independent perspectives to support the scale-up of our programme and to guide us through the years ahead.
Professor John Deanfield CBE
John Deanfield CBE, is Professor of Cardiology at University College London and Director of National Institute for Cardiovascular Outcomes Research (NICOR). His career has focused on the management of heart disease across the lifetime of an individual. He has actively worked towards improvements to cardiology, working on prevention, clinical care and the evaluation of outcomes.
As Director of NICOR, John oversees one of the largest longitudinal sets of cardiovascular electronic health records in the world, providing UK-wide data for NHS Quality Improvement, research and public engagement. John has also been announced as the first ever Government Champion for Personalised Prevention.
Welcoming John as a Trustee, Dr Raghib Ali, CEO and Chief Medical Officer of Our Future Health, said:
“We’re so pleased to have John joining our Board of Trustees. His wealth of knowledge and experience in the prevention and treatment of heart disease will be immensely helpful to our research programme, as we work towards helping millions of people live healthier lives for longer.”
Our Board of Trustees and Executive Team are supported by a range of advisory boards that provide expert guidance on important aspects of our programme, including ethics, science, diversity and technology.
More details about these groups and our wider governance structure can be read here.